The Wayne Francis Cancer Epidemiology Research Group

The Wayne Francis Cancer Epidemiology Research Group was established in 2011 as a partnership between the University of Canterbury School of Health Sciences and the Wayne Francis Charitable Trust.   

Epidemiology is the study of the distribution and determinants of health in populations, and the application of this study to the control of health problems.  Cancer is a significant health problem in New Zealand, with over 20,000 New Zealanders diagnosed with cancer each year.  The Wayne Francis Cancer Epidemiology Research Group was established to support and encourage research into the distribution and determinants of cancer, and efforts to reduce the impact of cancer.

 

Project Lead Investigators

Breast cancer, cytomegalovirus, and Epstein-Barr virus: nested case-control study
(In partnership with the Hugh Adam Cancer Epidemiology Unit University of Otago, and the University of Oslo)
Funded by the Health Research Council of New Zealand

Ann Richardson, Patrick Graham, Brian Cox, Halvor Rollag, John Potter
(with Eero Pukkala, Finnish Cancer Registry Institute for Statistical and Epidemiological Cancer Research and Heljä-Marja Surcel, National Institute for Health and Welfare, Finland).

Environmental risk factors for breast cancer Dr Wasan Ali (PhD)
Population attributable risks for breast cancer James Hayes

Cytomegalovirus Blood Donor Linkage Study 
(In partnership with the NZ Blood Service)

Ann Richardson, John Potter, Arindam Basu, Pat Coope, Krishna Badami.

Cytomegalovirus and Epstein-Barr virus in breast cancer and normal breast tissue
(In partnership with the University of Otago, Christchurch)
Funded by the Canterbury Medical Research Foundation

Ann Richardson, Bridget Robinson, Logan Walker, Margaret Currie, Helen Morrin, Elisabeth Wells, John Pearson, John Potter.

Support services for people with head and neck cancer
(In partnership with the Cancer Society and CDHB)

Ann Richardson, Kate Reid, Pauline Barnett, Liz Horn, Wendy Mann, Frankie Roake, Catherine Dwan, Rob Allison.

Ovarian cancer and contraception
(In partnership with the Hugh Adam Cancer Epidemiology Unit, University of Otago)
Funded by Genesis Oncology Trust

Ann Richardson, John Potter, Pat Coope, Mary Jane Sneyd, Jacqueline Chesang.

Patterns in male and female breast cancer
(In partnership with the University of Alberta)

Ann Richardson, John Potter, Yutaka Yasui, Erin Kreiter

 

Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H.  Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study.  Br J Cancer 2010; 102: 1665-1669.

Green T, Richardson A, Parry S.  Colonoscopy requirements of population screening for colorectal cancer in New Zealand. NZ Med J 2012; 125: 4-14.  

Hayes J, Richardson A, Frampton C.  Population attributable risks for modifiable lifestyle factors and breast cancer in New Zealand women.  Internal Medicine Journal 2013; doi: 10.1111/imj.12256

Kreiter E, Richardson A, Potter J, Yasui Y.  Breast cancer: trends in international incidence in men and women.  Br J Cancer 2014.

Parry S, Richardson A, Green T, Marshall B, Bissett I, Bloomfield A, Chadwick V, Cunningham C, Findlay M, Greer B, McMenamin J, Strid J, Robertson G, Teague C.  Prospects for population colorectal cancer screening in New Zealand.  NZ Med J 2007; 120 (1258).

Pearson JF, Alla S, Clarke G, Taylor BV, Miller D, Richardson A, Mason D.  Multiple sclerosis in New Zealand Maori. Multiple Sclerosis Journal 2014; advance online publication DOI: 10.1177/1352458514535130

Richardson A.  Investing in public health: barriers and possible solutions.  Journal of Public Health 2012; 34: 322-7. doi: 10.1093/pubmed/fds039. 

Richardson A.  Prostate cancer screening: is it possible to explain diametrically opposed views?  NZ Med J 2005.

Richardson A, Barnett P, Horn L, Reid K, Mann W, Roake F, Dwan C, Allison R, Mackay C. Support services for people who have undergone treatment for head and neck cancer: an approach to evaluating services.  J Hospital Admin 2014; 3: 119-26. DOI: 10.5430/jha.v3n4p119

Richardson A, Clarke G, Sabel CE, Pearson JF, Mason DF, Taylor BV.  Method for identifying eligible individuals for a prevalence survey in the absence of a disease register or population register. Internal Medicine Journal 2012; 42: 1207-1212.

Richardson A, Cox B, Brown T, Smale P.  The impact of breast cancer screening on breast cancer registrations in New Zealand.  NZ Med J 2005.

Richardson A, Cox B, McCredie MRE, Dite GS, Chang J-H, Gertig DM, Southey MC, Giles GG, Hopper JL. Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study.  Br J Cancer 2004: 90:2149-52.

Richardson A, Fletcher L, Sneyd MJ, Cox B, Reeder AI.  The incidence and thickness of cutaneous malignant melanoma in New Zealand 1994-2004.  NZ Med J 2008; 121: 18-26.

Richardson A, Graham P, Brown T, Smale P, Cox B.  Breast cancer detection rates and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme. J Med Screen 2004; 11: 65-9.

Richardson AK, Potter JD. Screening for Colorectal Cancer and Prostate Cancer: Challenges for New Zealand.  NZ Med J 2014; 127.

Taylor BV, Palmer A, Simpson S, Lucas R, Simmons RD, Mason D, Pearson J, Clarke G, Sabel C, Willoughby E, Richardson A, Abernethy D.  Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.  Multiple Sclerosis Journal 2013 doi:10.1177/135258513481511

For advice

John Potter

Adjunct Professor

Find research groups

Search our Research repository

News, events and seminars